Title:
【発明の名称】N.A.R.I.、好ましくはレボキセチンおよびピンドロールの新しい薬物組合せ
Document Type and Number:
Japanese Patent JP2002514601
Kind Code:
A
Abstract:
This patent application describes a new combination treatment of selective, noradrenaline-reuptake inhibitors (NARI) and specifically, reboxetine, and pindolol to provide rapid relief to patients suffering from depression, general anxiety, attention deficit hyperactivity disorder (ADHD), anxiety disorders such as obsessive compulsive disorders (OCD), panic disorders (PD), social phobia (SD) and the like.
Inventors:
Duncan Paul Taylor
Application Number:
JP2000547981A
Publication Date:
May 21, 2002
Filing Date:
April 14, 1999
Export Citation:
Assignee:
PHARMACIA&UPJOHN COMPANY
International Classes:
A61K31/404; A61K31/535; A61P25/00; A61P25/22; A61P25/24; A61P43/00; A61K31/5375; (IPC1-7): A61K31/5375; A61K31/404; A61P25/00; A61P25/22; A61P25/24; A61P43/00
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)